Skip to content

DR. CREEMERS ANN

Active Private limited companyfounded 2006active for 20 yearsBruglaan 9, 3960 BreeKBO/BCE: BE 0881.512.640 #4 company by total assets in Bree, Health and social work sector

Lifetime

19 annual accounts with figures on one time axis
peak of €467,444 in 2025
€467,444▲ 46.2%
lowest -€32,531 in 2016
€295,796▲ 67.5%
peak of €1.1m in 2025
€1.1m▲ 24.7%
€818,836▲ 3.4%
Board1 name since 2021
1 director
Documentsfilings and deeds
30-07-20261 day before the deadline
2025micro format
Gross margin from €319,755 to €467,444Result from €176,552 to €295,796Dividend €85,705Equity from €849,880 to €1.1mCash from €387,470 to €586,819

Key points

from the 2025 annual accounts

Equity

€1.1m ▲ 24.7%

DR. CREEMERS ANN has made a profit without a break since 2017.

Result

€295,796 ▲ 67.5%
€177,0002024€296,0002025

The result rose in 2025 from €176,552 to €295,796.

Filings

19 annual accounts since 2007
AprilJune31 JulyOctober2010201520202025

Five of the last ten came late. The 2016 accounts came in latest, 18 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 20,149 companies had the same profile as DR. CREEMERS ANN has now. Each dot stands for 51 companies, two years later.

95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 20,149 companies, not a prediction for DR. CREEMERS ANN. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director

Shares in 1 company,

Board & ownership

Recent changes

changes role from statutory manager to sole statutory director “Onderneming in onroerende goederen, welke onder meer omvat de verwerving, de vervreemding, het beheer, de…” (deed in Dutch) · General meeting of 17-03-2022 · Gazette deed
Purpose change “De uitoefening van de geneeskunde door de geneesheer-vennoot of geneesheer-vennoten, in naam en voor rekening…” (deed in Dutch) · Gazette deed
Amendment of the articles Gazette deed
First establishment Diestersteenweg 425, Maaseik
All 33 events

Comparable companies

same main activity, similar in size and age
Company
DR. CREEMERS ANN Bree €1.9m €467,444 56.4% -
PRIMROSE LABORATORIES Torhout €1.9m €436,874 -74.8% 5.2
DOKTER BARBARA DE CLERCQ Koksijde €1.8m €442,676 36.8% 1.9
MB DECLERCK Schoten €1.9m €463,084 76.9% 2
DOKTER LOUIS IDE Zwalm €2.0m €492,641 63.2% -
Dr. F. Desimpel Aalter €1.7m €401,113 65.5% -
DR. BECX PHILIPPE Bree €1.8m €357,156 86.5% -

These companies have the same main activity as DR. CREEMERS ANN: medical imaging and medical laboratories (NACE 86910). They are comparable in size and age: total assets between €1.7m and €2m, founded between 2004 and 2007.

Official details

Source: KBO
Status
Active since 18-05-2006Normal situation
Activity
Medical imaging and medical laboratoriesNACE 86910
Establishment unit
2.302.686.6613680 Maaseik, since 24-05-2006
Financial year end
31 December
Peppol
Reachable via Peppol
Company details

Annual accounts 2025

≈ €690,000estimated
€1.9m▲ 14.4%
Filing
Filed on 30-07-2026, 1 day before the end of the filing period
Financials

Insights on DR. CREEMERS ANN

DR. CREEMERS ANN files the micro format. That format states no turnover. The gross margin rose from €195,126 in 2007 to €467,444 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DR. CREEMERS ANN

What is the company number of DR. CREEMERS ANN?
The company number of DR. CREEMERS ANN is 0881.512.640. The VAT number is the same number with BE in front: BE 0881.512.640.
Where is DR. CREEMERS ANN based?
The registered office is at Bruglaan 9, 3960 Bree.Company details
What does DR. CREEMERS ANN do?
According to the KBO register, the main activity is medical imaging and medical laboratories (NACE 86910).
What is the legal form of DR. CREEMERS ANN?
DR. CREEMERS ANN is a private limited company (BV).
When was DR. CREEMERS ANN founded?
DR. CREEMERS ANN was founded on 18-05-2006.
Is DR. CREEMERS ANN still active?
Yes, DR. CREEMERS ANN is an active enterprise in the KBO register.
What is the turnover of DR. CREEMERS ANN?
The turnover in financial year 2025 is about €690,000. This figure is estimated from the gross margin of €467,444 and 48 comparable companies (NACE 86). It probably lies between €570,000 and €870,000.Financials
Is DR. CREEMERS ANN profitable?
In financial year 2025, DR. CREEMERS ANN made a profit of €295,796.
Where can I find the annual accounts of DR. CREEMERS ANN?
DR. CREEMERS ANN filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. CREEMERS ANN due?
DR. CREEMERS ANN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.